Intellipharmaceutics International Probability of Future OTC Stock Price Finishing Under 0.04
| IPCIFDelisted Stock | USD 0.04 0.00 0.00% |
Intellipharmaceutics |
Intellipharmaceutics Target Price Odds to finish below 0.04
The tendency of Intellipharmaceutics OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 0.04 after 90 days |
| 0.04 | 90 days | 0.04 | about 41.16 |
Based on a normal probability distribution, the odds of Intellipharmaceutics to stay under $ 0.04 after 90 days from now is about 41.16 (This Intellipharmaceutics International probability density function shows the probability of Intellipharmaceutics OTC Stock to fall within a particular range of prices over 90 days) . Probability of Intellipharmaceutics price to stay between its current price of $ 0.04 and $ 0.04 at the end of the 90-day period is about 5.82 .
Assuming the 90 days horizon Intellipharmaceutics International has a beta of -21.29. This usually indicates as returns on its benchmark rise, returns on holding Intellipharmaceutics International are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Intellipharmaceutics is expected to outperform its benchmark. In addition to that Intellipharmaceutics International has an alpha of 15.9275, implying that it can generate a 15.93 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Intellipharmaceutics Price Density |
| Price |
Predictive Modules for Intellipharmaceutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intellipharmaceutics. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Intellipharmaceutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Intellipharmaceutics is not an exception. The market had few large corrections towards the Intellipharmaceutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Intellipharmaceutics International, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Intellipharmaceutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 15.93 | |
β | Beta against Dow Jones | -21.29 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.17 |
Intellipharmaceutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Intellipharmaceutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Intellipharmaceutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Intellipharmaceutics is not yet fully synchronised with the market data | |
| Intellipharmaceutics has some characteristics of a very speculative penny stock | |
| Intellipharmaceutics has a very high chance of going through financial distress in the upcoming years | |
| Intellipharmaceutics has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Intellipharmaceutics International has accumulated 2.01 M in total debt with debt to equity ratio (D/E) of 165.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Intellipharmaceutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Intellipharmaceutics until it has trouble settling it off, either with new capital or with free cash flow. So, Intellipharmaceutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intellipharmaceutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intellipharmaceutics to invest in growth at high rates of return. When we think about Intellipharmaceutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (5.15 M) with profit before overhead, payroll, taxes, and interest of 1.4 M. | |
| Intellipharmaceutics International has accumulated about 79.65 K in cash with (2.46 M) of positive cash flow from operations. |
Intellipharmaceutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Intellipharmaceutics OTC Stock often depends not only on the future outlook of the current and potential Intellipharmaceutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intellipharmaceutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.1 M |
Intellipharmaceutics Technical Analysis
Intellipharmaceutics' future price can be derived by breaking down and analyzing its technical indicators over time. Intellipharmaceutics OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Intellipharmaceutics International. In general, you should focus on analyzing Intellipharmaceutics OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Intellipharmaceutics Predictive Forecast Models
Intellipharmaceutics' time-series forecasting models is one of many Intellipharmaceutics' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Intellipharmaceutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Intellipharmaceutics
Checking the ongoing alerts about Intellipharmaceutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Intellipharmaceutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Intellipharmaceutics is not yet fully synchronised with the market data | |
| Intellipharmaceutics has some characteristics of a very speculative penny stock | |
| Intellipharmaceutics has a very high chance of going through financial distress in the upcoming years | |
| Intellipharmaceutics has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Intellipharmaceutics International has accumulated 2.01 M in total debt with debt to equity ratio (D/E) of 165.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Intellipharmaceutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Intellipharmaceutics until it has trouble settling it off, either with new capital or with free cash flow. So, Intellipharmaceutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intellipharmaceutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intellipharmaceutics to invest in growth at high rates of return. When we think about Intellipharmaceutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (5.15 M) with profit before overhead, payroll, taxes, and interest of 1.4 M. | |
| Intellipharmaceutics International has accumulated about 79.65 K in cash with (2.46 M) of positive cash flow from operations. |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Intellipharmaceutics OTC Stock
If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets |